During the recent Bio-IT World Conference, David Glazer, Verily Distinguished Engineer, presented on "Solving for friction: Next-generation TREs for accelerating discovery." He highlighted three key barriers slowing biomedical discovery: • Policy friction (complex data use agreements) • Science friction (time spent on data wrangling) • Technology friction (fragmented tooling) Verily Pre, our AI-native platform for precision health, is designed to reduce this friction. It includes Refinery for data cleaning, Exchange for data discovery, and Workbench as an intuitive Trusted Research Environment (TRE) for secure analysis. During the conference, Jonathan Z Amar, Verily AI and Data Science Manager, joined a panel discussing data-specialized foundation models (FMs). He shared Verily’s approach to training a multi-modal foundation model on the All of Us (AOU) Research Program data, and how that might unblock new insights to predict disease risk and improve our understanding of health over time.
⚽ Ready for the 2026 world soccer games to kick off next week? We are! As part of a coalition effort to protect public health throughout the event, Verily Health will test wastewater samples for pathogens such as SARS-CoV-2, influenza, RSV, norovirus, and measles, and aggregate wastewater data from additional sources. Check our dashboard for regular updates on pathogen trends and clear, actionable analysis from Katelyn Jetelina, PhD, MPH, of Your Local Epidemiologist. Stay informed and bookmark veri.ly/world-soccer!
Carolyn Bradner Jasik, MD, Verily Health Associate Chief Clinical Officer, will be speaking at AHIP 2026 about the path towards AI-enabled care. This 15-minute session on Tuesday, June 9 at 8:45am PT dives into a new category of care driven by AI and how we get there.
Most AI guardrails are built for general-purpose tasks, like catching policy or rules violations. Because they aren't specialized, these tools often miss the subtle signs that someone is in a mental health crisis. At Verily Health, we’ve created technology specifically for healthcare. Our new research in NPJ Digital Medicine explains how we built a safety system and a dataset designed for clinical needs. Our guardrail catches signs of distress that general AI guardrails miss. This means we can detect true crises more consistently. Read the full details of our publication and benchmark dataset.
The theme for this year’s Clinical Trials Day was "Research Rising" — a movement for more inclusive, patient-centered research. 🌟 Researchers have the opportunity to unlock breakthroughs with more access to a continuous, "living evidence story" that understands a patient's real-world behaviors and journey over the long term. The Verily Lifelong Health Study provides research opportunities for consented participants to securely integrate their multimodal health data. By linking clinical records (EHR) and lifestyle inputs to wearable devices and contextual surveys, the study creates a single, high definition longitudinal view. For researchers, this provides the real-world evidence needed to accelerate personalized breakthroughs and understand the long-term effects of treatments. For participants, it fundamentally shifts the dynamic from passive "research subject" to an "engaged health partner" — ensuring research truly rises to meet the needs of all patients.
Great to see the recent publication of results from the HERO-Together Study, a multi-year, prospective study to understand the long-term safety of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2), co-authored by researchers from Duke University, Pfizer and Verily Health. We are proud to have contributed to this effort by developing the secure, participant-facing portal that powered the study's clinical data management and enabled a high-engagement, longitudinal approach to collecting safety information. The results support a favorable long-term safety profile of BNT162b2 in real-world settings.
Our CEO Stephen Gillett’s experience at Chronicle, a cybersecurity moonshot that started at X, The Moonshot Factory, underscored a crucial lesson: technology alone is not enough. When it comes to AI workflows in both cybersecurity and health, you need to apply “human-in-the loop” thinking, knowing what signals you’re looking for and designing systems with the right notifications to be successful.
Agentic AI for enterprise health care remains primarily in the back office rather than at the bedside. According to a recent American Medical Association survey*, 81% of physicians now use AI in their practice, but mostly for administrative workflows, even though 76% see an advantage to using AI tools in patient care. Only 17% of physicians reported use of AI for assistive diagnosis and the reported use for patient-facing recommendations was much lower. ✨ What will it take for us to embrace the role of AI as part of the patient’s care team?
The National Institutes of Health (NIH) All of Us Research Program has over 881,000 participants and 22,800 researchers partnering to accelerate research advances and precision medicine. In collaboration with Vanderbilt University Medical Center, we are proud to power the recently updated Researcher Workbench using Verily Workbench on our secure precision health platform, Pre. Researchers have access to the most advanced tools to unlock insights from the dataset, which includes whole genome sequences, electronic health records, and more.
Join Verily Health and our partners Transcripta Bio, Segmed, Inc., and RefinedScience to discover a seamless path from data discovery to insight. In our upcoming webinar, "Accelerating research with multimodal datasets on Verily Exchange," we will showcase how combining Verily’s AI-native Pre infrastructure with unique, specialized datasets solves key use cases across the drug development lifecycle. What you’ll learn: • Navigating the discovery engine: Understand how Verily’s AI-native Pre platform streamlines the path from data discovery to insights • Exploring specialized datasets: Get an inside look at AI-ready datasets for neurology, oncology, and hematology-oncology. 📅 Wednesday, May 27, 2026 🕙 10 am PT / 1 pm ET
